<DOC>
	<DOC>NCT00434785</DOC>
	<brief_summary>To assess the safety and tolerability of ascending, multiple oral doses of AGG-523 in healthy Japanese subjects.</brief_summary>
	<brief_title>A Study of the Safety, Tolerability, and Pharmacokinetics of AGG-523 in Healthy Japanese Males</brief_title>
	<detailed_description />
	<criteria>Men aged 20 to 40 years, inclusive, at screening; sexually active men must agree to use a medically acceptable form of contraception during the study and continue for 12 weeks after test article administration. Body mass index (BMI) in the range of 17.6 to 26.4 Kgm2, and body weight &gt;45 kg. Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12 lead ECG.</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>